Industry Research Reports

Home > Reports > Chemical & Material > Global Filgotinib Market Research Report 2025

Global Filgotinib Market Research Report 2025

Industry: Chemical & Material

Published Date: 2025-02-15

Pages: 100 Pages

Report ld: 3952439

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Filgotinib was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.

North American market for Filgotinib is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Filgotinib is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Filgotinib include Cayman Chemical, BioVision, Adooq Bioscience, Taiclone, Clearsynth, Biorbyt, APExBIO Technology, Selleck Chemicals, AbMole, BOC Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

MARKET SEGMENTATION

By Company

Cayman Chemical
BioVision
Adooq Bioscience
Taiclone
Clearsynth
Biorbyt
APExBIO Technology
Selleck Chemicals
AbMole
BOC Sciences
TargetMol
Toronto Research Chemicals
J&K Scientific

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%

Segment by Application

Research
Medical

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Filgotinib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Filgotinib.

The Filgotinib market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Filgotinib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Filgotinib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Filgotinib manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Production/output, value of Filgotinib by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 4: Consumption of Filgotinib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Filgotinib Market Overview

1.1 Product Definition

1.2 Filgotinib by Type

1.2.1 Global Filgotinib Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 Min Purity Less Than 98%

1.2.3 Min Purity 98%-99%

1.2.4 Min Purity More Than 99%

1.3 Filgotinib by Application

1.3.1 Global Filgotinib Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Research

1.3.3 Medical

1.4 Global Market Growth Prospects

1.4.1 Global Filgotinib Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global Filgotinib Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global Filgotinib Production Estimates and Forecasts (2020-2031)

1.4.4 Global Filgotinib Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Filgotinib Production Market Share by Manufacturers (2020-2025)

2.2 Global Filgotinib Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of Filgotinib, Industry Ranking, 2023 VS 2024

2.4 Global Filgotinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Filgotinib Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of Filgotinib, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Filgotinib, Product Offered and Application

2.8 Global Key Manufacturers of Filgotinib, Date of Enter into This Industry

2.9 Filgotinib Market Competitive Situation and Trends

2.9.1 Filgotinib Market Concentration Rate

2.9.2 Global 5 and 10 Largest Filgotinib Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Filgotinib Production by Region

3.1 Global Filgotinib Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global Filgotinib Production Value by Region (2020-2031)

3.2.1 Global Filgotinib Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of Filgotinib by Region (2026-2031)

3.3 Global Filgotinib Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global Filgotinib Production Volume by Region (2020-2031)

3.4.1 Global Filgotinib Production by Region (2020-2025)

3.4.2 Global Forecasted Production of Filgotinib by Region (2026-2031)

3.5 Global Filgotinib Market Price Analysis by Region (2020-2025)

3.6 Global Filgotinib Production and Value, Year-over-Year Growth

3.6.1 North America Filgotinib Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe Filgotinib Production Value Estimates and Forecasts (2020-2031)

3.6.3 China Filgotinib Production Value Estimates and Forecasts (2020-2031)

3.6.4 Japan Filgotinib Production Value Estimates and Forecasts (2020-2031)

3.6.5 Taiwan,China Filgotinib Production Value Estimates and Forecasts (2020-2031)

3.6.6 India Filgotinib Production Value Estimates and Forecasts (2020-2031)

4 Filgotinib Consumption by Region

4.1 Global Filgotinib Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global Filgotinib Consumption by Region (2020-2031)

4.2.1 Global Filgotinib Consumption by Region (2020-2025)

4.2.2 Global Filgotinib Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America Filgotinib Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America Filgotinib Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Filgotinib Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe Filgotinib Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Filgotinib Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific Filgotinib Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Filgotinib Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa Filgotinib Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Filgotinib Production by Type (2020-2031)

5.1.1 Global Filgotinib Production by Type (2020-2025)

5.1.2 Global Filgotinib Production by Type (2026-2031)

5.1.3 Global Filgotinib Production Market Share by Type (2020-2031)

5.2 Global Filgotinib Production Value by Type (2020-2031)

5.2.1 Global Filgotinib Production Value by Type (2020-2025)

5.2.2 Global Filgotinib Production Value by Type (2026-2031)

5.2.3 Global Filgotinib Production Value Market Share by Type (2020-2031)

5.3 Global Filgotinib Price by Type (2020-2031)

6 Segment by Application

6.1 Global Filgotinib Production by Application (2020-2031)

6.1.1 Global Filgotinib Production by Application (2020-2025)

6.1.2 Global Filgotinib Production by Application (2026-2031)

6.1.3 Global Filgotinib Production Market Share by Application (2020-2031)

6.2 Global Filgotinib Production Value by Application (2020-2031)

6.2.1 Global Filgotinib Production Value by Application (2020-2025)

6.2.2 Global Filgotinib Production Value by Application (2026-2031)

6.2.3 Global Filgotinib Production Value Market Share by Application (2020-2031)

6.3 Global Filgotinib Price by Application (2020-2031)

7 Key Companies Profiled

7.1 Cayman Chemical

7.1.1 Cayman Chemical Filgotinib Company Information

7.1.2 Cayman Chemical Filgotinib Product Portfolio

7.1.3 Cayman Chemical Filgotinib Production, Value, Price and Gross Margin (2020-2025)

7.1.4 Cayman Chemical Main Business and Markets Served

7.1.5 Cayman Chemical Recent Developments/Updates

7.2 BioVision

7.2.1 BioVision Filgotinib Company Information

7.2.2 BioVision Filgotinib Product Portfolio

7.2.3 BioVision Filgotinib Production, Value, Price and Gross Margin (2020-2025)

7.2.4 BioVision Main Business and Markets Served

7.2.5 BioVision Recent Developments/Updates

7.3 Adooq Bioscience

7.3.1 Adooq Bioscience Filgotinib Company Information

7.3.2 Adooq Bioscience Filgotinib Product Portfolio

7.3.3 Adooq Bioscience Filgotinib Production, Value, Price and Gross Margin (2020-2025)

7.3.4 Adooq Bioscience Main Business and Markets Served

7.3.5 Adooq Bioscience Recent Developments/Updates

7.4 Taiclone

7.4.1 Taiclone Filgotinib Company Information

7.4.2 Taiclone Filgotinib Product Portfolio

7.4.3 Taiclone Filgotinib Production, Value, Price and Gross Margin (2020-2025)

7.4.4 Taiclone Main Business and Markets Served

7.4.5 Taiclone Recent Developments/Updates

7.5 Clearsynth

7.5.1 Clearsynth Filgotinib Company Information

7.5.2 Clearsynth Filgotinib Product Portfolio

7.5.3 Clearsynth Filgotinib Production, Value, Price and Gross Margin (2020-2025)

7.5.4 Clearsynth Main Business and Markets Served

7.5.5 Clearsynth Recent Developments/Updates

7.6 Biorbyt

7.6.1 Biorbyt Filgotinib Company Information

7.6.2 Biorbyt Filgotinib Product Portfolio

7.6.3 Biorbyt Filgotinib Production, Value, Price and Gross Margin (2020-2025)

7.6.4 Biorbyt Main Business and Markets Served

7.6.5 Biorbyt Recent Developments/Updates

7.7 APExBIO Technology

7.7.1 APExBIO Technology Filgotinib Company Information

7.7.2 APExBIO Technology Filgotinib Product Portfolio

7.7.3 APExBIO Technology Filgotinib Production, Value, Price and Gross Margin (2020-2025)

7.7.4 APExBIO Technology Main Business and Markets Served

7.7.5 APExBIO Technology Recent Developments/Updates

7.8 Selleck Chemicals

7.8.1 Selleck Chemicals Filgotinib Company Information

7.8.2 Selleck Chemicals Filgotinib Product Portfolio

7.8.3 Selleck Chemicals Filgotinib Production, Value, Price and Gross Margin (2020-2025)

7.8.4 Selleck Chemicals Main Business and Markets Served

7.8.5 Selleck Chemicals Recent Developments/Updates

7.9 AbMole

7.9.1 AbMole Filgotinib Company Information

7.9.2 AbMole Filgotinib Product Portfolio

7.9.3 AbMole Filgotinib Production, Value, Price and Gross Margin (2020-2025)

7.9.4 AbMole Main Business and Markets Served

7.9.5 AbMole Recent Developments/Updates

7.10 BOC Sciences

7.10.1 BOC Sciences Filgotinib Company Information

7.10.2 BOC Sciences Filgotinib Product Portfolio

7.10.3 BOC Sciences Filgotinib Production, Value, Price and Gross Margin (2020-2025)

7.10.4 BOC Sciences Main Business and Markets Served

7.10.5 BOC Sciences Recent Developments/Updates

7.11 TargetMol

7.11.1 TargetMol Filgotinib Company Information

7.11.2 TargetMol Filgotinib Product Portfolio

7.11.3 TargetMol Filgotinib Production, Value, Price and Gross Margin (2020-2025)

7.11.4 TargetMol Main Business and Markets Served

7.11.5 TargetMol Recent Developments/Updates

7.12 Toronto Research Chemicals

7.12.1 Toronto Research Chemicals Filgotinib Company Information

7.12.2 Toronto Research Chemicals Filgotinib Product Portfolio

7.12.3 Toronto Research Chemicals Filgotinib Production, Value, Price and Gross Margin (2020-2025)

7.12.4 Toronto Research Chemicals Main Business and Markets Served

7.12.5 Toronto Research Chemicals Recent Developments/Updates

7.13 J&K Scientific

7.13.1 J&K Scientific Filgotinib Company Information

7.13.2 J&K Scientific Filgotinib Product Portfolio

7.13.3 J&K Scientific Filgotinib Production, Value, Price and Gross Margin (2020-2025)

7.13.4 J&K Scientific Main Business and Markets Served

7.13.5 J&K Scientific Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Filgotinib Industry Chain Analysis

8.2 Filgotinib Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Filgotinib Production Mode & Process Analysis

8.4 Filgotinib Sales and Marketing

8.4.1 Filgotinib Sales Channels

8.4.2 Filgotinib Distributors

8.5 Filgotinib Customer Analysis

9 Filgotinib Market Dynamics

9.1 Filgotinib Industry Trends

9.2 Filgotinib Market Drivers

9.3 Filgotinib Market Challenges

9.4 Filgotinib Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Filgotinib Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Filgotinib Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global Filgotinib Production Capacity (Kg) by Manufacturers in 2024

Table 4. Global Filgotinib Production by Manufacturers (2020-2025) & (Kg)

Table 5. Global Filgotinib Production Market Share by Manufacturers (2020-2025)

Table 6. Global Filgotinib Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global Filgotinib Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of Filgotinib, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Filgotinib as of 2024)

Table 10. Global Market Filgotinib Average Price by Manufacturers (K USD/Kg) & (2020-2025)

Table 11. Global Key Manufacturers of Filgotinib, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of Filgotinib, Product Offered and Application

Table 13. Global Key Manufacturers of Filgotinib, Date of Enter into This Industry

Table 14. Global Filgotinib Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Filgotinib Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Filgotinib Production Value (US$ Million) by Region (2020-2025)

Table 18. Global Filgotinib Production Value Market Share by Region (2020-2025)

Table 19. Global Filgotinib Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global Filgotinib Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global Filgotinib Production Comparison by Region: 2020 VS 2024 VS 2031 (Kg)

Table 22. Global Filgotinib Production (Kg) by Region (2020-2025)

Table 23. Global Filgotinib Production Market Share by Region (2020-2025)

Table 24. Global Filgotinib Production (Kg) Forecast by Region (2026-2031)

Table 25. Global Filgotinib Production Market Share Forecast by Region (2026-2031)

Table 26. Global Filgotinib Market Average Price (K USD/Kg) by Region (2020-2025)

Table 27. Global Filgotinib Market Average Price (K USD/Kg) by Region (2026-2031)

Table 28. Global Filgotinib Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kg)

Table 29. Global Filgotinib Consumption by Region (2020-2025) & (Kg)

Table 30. Global Filgotinib Consumption Market Share by Region (2020-2025)

Table 31. Global Filgotinib Forecasted Consumption by Region (2026-2031) & (Kg)

Table 32. Global Filgotinib Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America Filgotinib Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)

Table 34. North America Filgotinib Consumption by Country (2020-2025) & (Kg)

Table 35. North America Filgotinib Consumption by Country (2026-2031) & (Kg)

Table 36. Europe Filgotinib Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)

Table 37. Europe Filgotinib Consumption by Country (2020-2025) & (Kg)

Table 38. Europe Filgotinib Consumption by Country (2026-2031) & (Kg)

Table 39. Asia Pacific Filgotinib Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kg)

Table 40. Asia Pacific Filgotinib Consumption by Region (2020-2025) & (Kg)

Table 41. Asia Pacific Filgotinib Consumption by Region (2026-2031) & (Kg)

Table 42. Latin America, Middle East & Africa Filgotinib Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)

Table 43. Latin America, Middle East & Africa Filgotinib Consumption by Country (2020-2025) & (Kg)

Table 44. Latin America, Middle East & Africa Filgotinib Consumption by Country (2026-2031) & (Kg)

Table 45. Global Filgotinib Production (Kg) by Type (2020-2025)

Table 46. Global Filgotinib Production (Kg) by Type (2026-2031)

Table 47. Global Filgotinib Production Market Share by Type (2020-2025)

Table 48. Global Filgotinib Production Market Share by Type (2026-2031)

Table 49. Global Filgotinib Production Value (US$ Million) by Type (2020-2025)

Table 50. Global Filgotinib Production Value (US$ Million) by Type (2026-2031)

Table 51. Global Filgotinib Production Value Market Share by Type (2020-2025)

Table 52. Global Filgotinib Production Value Market Share by Type (2026-2031)

Table 53. Global Filgotinib Price (K USD/Kg) by Type (2020-2025)

Table 54. Global Filgotinib Price (K USD/Kg) by Type (2026-2031)

Table 55. Global Filgotinib Production (Kg) by Application (2020-2025)

Table 56. Global Filgotinib Production (Kg) by Application (2026-2031)

Table 57. Global Filgotinib Production Market Share by Application (2020-2025)

Table 58. Global Filgotinib Production Market Share by Application (2026-2031)

Table 59. Global Filgotinib Production Value (US$ Million) by Application (2020-2025)

Table 60. Global Filgotinib Production Value (US$ Million) by Application (2026-2031)

Table 61. Global Filgotinib Production Value Market Share by Application (2020-2025)

Table 62. Global Filgotinib Production Value Market Share by Application (2026-2031)

Table 63. Global Filgotinib Price (K USD/Kg) by Application (2020-2025)

Table 64. Global Filgotinib Price (K USD/Kg) by Application (2026-2031)

Table 65. Cayman Chemical Filgotinib Company Information

Table 66. Cayman Chemical Filgotinib Specification and Application

Table 67. Cayman Chemical Filgotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2020-2025)

Table 68. Cayman Chemical Main Business and Markets Served

Table 69. Cayman Chemical Recent Developments/Updates

Table 70. BioVision Filgotinib Company Information

Table 71. BioVision Filgotinib Specification and Application

Table 72. BioVision Filgotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2020-2025)

Table 73. BioVision Main Business and Markets Served

Table 74. BioVision Recent Developments/Updates

Table 75. Adooq Bioscience Filgotinib Company Information

Table 76. Adooq Bioscience Filgotinib Specification and Application

Table 77. Adooq Bioscience Filgotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2020-2025)

Table 78. Adooq Bioscience Main Business and Markets Served

Table 79. Adooq Bioscience Recent Developments/Updates

Table 80. Taiclone Filgotinib Company Information

Table 81. Taiclone Filgotinib Specification and Application

Table 82. Taiclone Filgotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2020-2025)

Table 83. Taiclone Main Business and Markets Served

Table 84. Taiclone Recent Developments/Updates

Table 85. Clearsynth Filgotinib Company Information

Table 86. Clearsynth Filgotinib Specification and Application

Table 87. Clearsynth Filgotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2020-2025)

Table 88. Clearsynth Main Business and Markets Served

Table 89. Clearsynth Recent Developments/Updates

Table 90. Biorbyt Filgotinib Company Information

Table 91. Biorbyt Filgotinib Specification and Application

Table 92. Biorbyt Filgotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2020-2025)

Table 93. Biorbyt Main Business and Markets Served

Table 94. Biorbyt Recent Developments/Updates

Table 95. APExBIO Technology Filgotinib Company Information

Table 96. APExBIO Technology Filgotinib Specification and Application

Table 97. APExBIO Technology Filgotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2020-2025)

Table 98. APExBIO Technology Main Business and Markets Served

Table 99. APExBIO Technology Recent Developments/Updates

Table 100. Selleck Chemicals Filgotinib Company Information

Table 101. Selleck Chemicals Filgotinib Specification and Application

Table 102. Selleck Chemicals Filgotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2020-2025)

Table 103. Selleck Chemicals Main Business and Markets Served

Table 104. Selleck Chemicals Recent Developments/Updates

Table 105. AbMole Filgotinib Company Information

Table 106. AbMole Filgotinib Specification and Application

Table 107. AbMole Filgotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2020-2025)

Table 108. AbMole Main Business and Markets Served

Table 109. AbMole Recent Developments/Updates

Table 110. BOC Sciences Filgotinib Company Information

Table 111. BOC Sciences Filgotinib Specification and Application

Table 112. BOC Sciences Filgotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2020-2025)

Table 113. BOC Sciences Main Business and Markets Served

Table 114. BOC Sciences Recent Developments/Updates

Table 115. TargetMol Filgotinib Company Information

Table 116. TargetMol Filgotinib Specification and Application

Table 117. TargetMol Filgotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2020-2025)

Table 118. TargetMol Main Business and Markets Served

Table 119. TargetMol Recent Developments/Updates

Table 120. Toronto Research Chemicals Filgotinib Company Information

Table 121. Toronto Research Chemicals Filgotinib Specification and Application

Table 122. Toronto Research Chemicals Filgotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2020-2025)

Table 123. Toronto Research Chemicals Main Business and Markets Served

Table 124. Toronto Research Chemicals Recent Developments/Updates

Table 125. J&K Scientific Filgotinib Company Information

Table 126. J&K Scientific Filgotinib Specification and Application

Table 127. J&K Scientific Filgotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2020-2025)

Table 128. J&K Scientific Main Business and Markets Served

Table 129. J&K Scientific Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Filgotinib Distributors List

Table 133. Filgotinib Customers List

Table 134. Filgotinib Market Trends

Table 135. Filgotinib Market Drivers

Table 136. Filgotinib Market Challenges

Table 137. Filgotinib Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Product Picture of Filgotinib

Figure 2. Global Filgotinib Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Filgotinib Market Share by Type: 2024 VS 2031

Figure 4. Min Purity Less Than 98% Product Picture

Figure 5. Min Purity 98%-99% Product Picture

Figure 6. Min Purity More Than 99% Product Picture

Figure 7. Global Filgotinib Market Value by Application, (US$ Million) & (2020-2031)

Figure 8. Global Filgotinib Market Share by Application: 2024 VS 2031

Figure 9. Research

Figure 10. Medical

Figure 11. Global Filgotinib Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Filgotinib Production Value (US$ Million) & (2020-2031)

Figure 13. Global Filgotinib Production Capacity (Kg) & (2020-2031)

Figure 14. Global Filgotinib Production (Kg) & (2020-2031)

Figure 15. Global Filgotinib Average Price (K USD/Kg) & (2020-2031)

Figure 16. Filgotinib Report Years Considered

Figure 17. Filgotinib Production Share by Manufacturers in 2024

Figure 18. Global Filgotinib Production Value Share by Manufacturers (2024)

Figure 19. Filgotinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. The Global 5 and 10 Largest Players: Market Share by Filgotinib Revenue in 2024

Figure 21. Global Filgotinib Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 22. Global Filgotinib Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 23. Global Filgotinib Production Comparison by Region: 2020 VS 2024 VS 2031 (Kg)

Figure 24. Global Filgotinib Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 25. North America Filgotinib Production Value (US$ Million) Growth Rate (2020-2031)

Figure 26. Europe Filgotinib Production Value (US$ Million) Growth Rate (2020-2031)

Figure 27. China Filgotinib Production Value (US$ Million) Growth Rate (2020-2031)

Figure 28. Japan Filgotinib Production Value (US$ Million) Growth Rate (2020-2031)

Figure 29. Taiwan,China Filgotinib Production Value (US$ Million) Growth Rate (2020-2031)

Figure 30. India Filgotinib Production Value (US$ Million) Growth Rate (2020-2031)

Figure 31. Global Filgotinib Consumption by Region: 2020 VS 2024 VS 2031 (Kg)

Figure 32. Global Filgotinib Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 33. North America Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 34. North America Filgotinib Consumption Market Share by Country (2020-2031)

Figure 35. U.S. Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 36. Canada Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 37. Europe Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 38. Europe Filgotinib Consumption Market Share by Country (2020-2031)

Figure 39. Germany Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 40. France Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 41. U.K. Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 42. Italy Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 43. Russia Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 44. Asia Pacific Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 45. Asia Pacific Filgotinib Consumption Market Share by Region (2020-2031)

Figure 46. China Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 47. Japan Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 48. South Korea Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 49. China Taiwan Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 50. Southeast Asia Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 51. India Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 52. Latin America, Middle East & Africa Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 53. Latin America, Middle East & Africa Filgotinib Consumption Market Share by Country (2020-2031)

Figure 54. Mexico Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 55. Brazil Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 56. Turkey Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 57. GCC Countries Filgotinib Consumption and Growth Rate (2020-2031) & (Kg)

Figure 58. Global Production Market Share of Filgotinib by Type (2020-2031)

Figure 59. Global Production Value Market Share of Filgotinib by Type (2020-2031)

Figure 60. Global Filgotinib Price (K USD/Kg) by Type (2020-2031)

Figure 61. Global Production Market Share of Filgotinib by Application (2020-2031)

Figure 62. Global Production Value Market Share of Filgotinib by Application (2020-2031)

Figure 63. Global Filgotinib Price (K USD/Kg) by Application (2020-2031)

Figure 64. Filgotinib Value Chain

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Filgotinib market? zhanKai

The top companies in the global Filgotinib market are Cayman Chemical、BioVision、Adooq Bioscience.

Related Reports

Filgotinib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Filgotinib was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 141
USD 3950.00
(Single User License)
Global Filgotinib Market Research Report 2026
The global Filgotinib market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 144
USD 2900.00
(Single User License)
Global Filgotinib Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Filgotinib market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 156
USD 4900.00
(Single User License)
Filgotinib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Filgotinib was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 118
USD 3950.00
(Single User License)
Global Filgotinib Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Filgotinib market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 93
USD 4250.00
(Single User License)
Global Filgotinib Market Insights, Forecast to 2030
Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
Published Date: 2024-04-07
Pages: 105
USD 4900.00
(Single User License)
Filgotinib - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
Published Date: 2024-02-19
Pages: 126
USD 3950.00
(Single User License)
Global Filgotinib Market Research Report 2024
Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
Published Date: 2024-01-12
Pages: 97
USD 2900.00
(Single User License)

Filgotinib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Filgotinib was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 141
USD 3950.00 (Single User License)
Global Filgotinib Market Research Report 2026
The global Filgotinib market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 144
USD 2900.00 (Single User License)
Global Filgotinib Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Filgotinib market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 156
USD 4900.00 (Single User License)
Filgotinib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Filgotinib was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 118
USD 3950.00 (Single User License)
Global Filgotinib Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Filgotinib market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 93
USD 4250.00 (Single User License)
Global Filgotinib Market Insights, Forecast to 2030
Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
Published: 2024-04-07
Pages: 105
USD 4900.00 (Single User License)
Filgotinib - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
Published: 2024-02-19
Pages: 126
USD 3950.00 (Single User License)
Global Filgotinib Market Research Report 2024
Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
Published: 2024-01-12
Pages: 97
USD 2900.00 (Single User License)